Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082193 | SCV000563762 | likely benign | Gastrointestinal stromal tumor; Paragangliomas 4; Pheochromocytoma | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561330 | SCV000675072 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000841202 | SCV000983160 | likely benign | not provided | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000841202 | SCV001147170 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | SDHB: BP4, BP7 |
Color Diagnostics, |
RCV003514367 | SCV004362271 | likely benign | Paragangliomas 4 | 2022-10-20 | criteria provided, single submitter | clinical testing |